GASTRORESISTANT PHARMACEUTICAL DOSAGE FORM COMPRISING N-(2-(2-PHTHALIMIDOETHOXY)-ACETYL)-L-ALANYL-D-GLUTAMIC ACID (LK-423)

摘要

THE PRESENT INVENTION RELATES TO THE PHARMACEUTICAL DOSAGE FORMS WHICH ENABLE A CONTROLLED AND/OR A TARGETED DELIVERY OF AN ACTIVE SUBSTANCE TO THE SELECTED REGIONS OF GASTROINTESTINAL TRACT OF HUMANS OR ANIMALS. THE PHARMACEUTICAL DOSAGE FORMS PREFERABLY COMPRISES THE ACTIVE SUBSTANCE N-(2- (2-PHTHALIMIDOETHOXY)-ACETYL)-L-ALANYL-D-GLUTAMIC ACID (DESIGNATED AS LK 423). METHODS OF TREATMENT OF CHRONIC INFLAMMATORY DISEASES OF GASTROINTESTINAL TRACT OF HUMANS AND / OR ANIMALS BY USING THE PHARMACEUTICAL DOSAGE FORMS OF THE INVENTION ARE DISCLOSED.